Albion News


Keith Wallington Appointed as Chairman

MPP Global, a high growth technology business delivering digital monetization services to the media, sport and retail sectors, has completed a £12m ($15M) Series B financing round from Albion and Grafton Capital.

Based in Warrington, UK, MPP Global counts major global media companies including Sky, News UK, Daily Mail Group, L’Equipe and McClatchy among its clients. MPP Global’s platform, eSuite, converts and retains paid users for its clients, and is unique in its... read more


To quote the FT 'Innovative and fast-growing companies are the driving force of the European economy in the 21st century. They generate jobs and sustain Europe’s competitiveness.'

Congratulations to the team at Black Swan from everyone at Albion. To see the full list - ... read more

The OLIM Charity Conference

If you are a trustee of a charity we would very much like you to join us in central London on June 8th for our first Charity Conference. The conference will explore external influences currently facing charity trustees and executives, including global trends, pressures on donors, changing legal frameworks and investment strategies. The agenda will start with registration at 10:00am and finish with drinks and a buffet lunch closing at around 2:30.

If you would like to come along then please email with... read more

Quantexa, the disruptive big data and analytics company backed by Albion and HSBC, has opened a new office in Brussels. Further offices in Sydney and New York are due to open within the next 12 months.

Following on from last month’s $3.3m fund raising, Quantexa’s expansion reflects a growing customer base outside the UK. The Brussels office, with an initial staff of four, will put the company in closer proximity to its clients and forms part of its aggressive international growth plans. Quantexa’s clients include some of the world’s largest financial... read more


The magazine aims to give you an overview of Albions' recent developments, investment sector insight from our partners and a performance update with a Q&A on our VCTs. We are also delighted to introduce you to OLIM Investment Managers. 

To view the magazine electronically, please click here.

read more


Entity Resolution and Network Analytics start-up plans further product development and international expansion

Quantexa Limited (“Quantexa” or the “Company”) today announced that it has closed a $3.3 million investment, led by Albion and HSBC. Quantexa’s rapid growth has underpinned a Series A fundraising within its first year, with the new capital used to further accelerate product development and international expansion.

Founded in 2016 by a team of world-class software, data and advanced analytics experts, Quantexa currently uses big data analytics to... read more


memsstar Ltd. and Plasma-Therm LLC, both leading providers of semiconductor processing equipment for specialty markets, announced today that they have entered into a distribution agreement for North America. 

The agreement gives Plasma-Therm the exclusive rights to distribute all release products (HF and XeF2) as well as self-assembled monolayer (SAM) products from memsstar, adding to Plasma-Therm’s deep silicon etch (DSETM) and plasma-enhanced chemical vapor deposition (PECVD) portfolio.

The two companies can now deliver complete MEMS fabrication solutions... read more

Health Investor Awards 2017


We are very pleased to announce that, once again, Albion has been shortlisted for HealthInvestor of the Year 2017 (investment size < £10million)

read more


Automotive technology specialists SBD win place on league table of Britain’s fastest-growing SME exporters

  • SBD ranked 64th in Sunday Times Lloyds SME Export Track 100 league table
  • More than 50% annual international sales growth over two years
  • Between 2016 and 2020, car manufacturers are predicted to spend €42 billion on connected car services and autonomous technologies

Published this weekend, the 3rd annual Sunday Times Lloyds SME Export Track 100 league table ranked Britain’s small and medium-sized... read more


Albion portfolio company, Proveca, announced that it has raised £4m to fund the commercial launch of Sialanar® and the development and commercialisation of its paediatric product portfolio. Sialanar® is a treatment for chronic pathological drooling in children, launched in the UK by Proveca, to be followed by the rest of Europe. The investment was led by Catapult Ventures, managers of the GM&C Life Sciences Fund, alongside Kreos Capital, a leading European provider of growth debt financing, in a deal advised by Longcross Advisers.

The investment comes soon after the EU-... read more